Literature DB >> 24013355

Novel insights in genetic transformation of the probiotic yeast Saccharomyces boulardii.

Bruno Douradinha1, Viviane C B Reis2, Matthew B Rogers3, Fernando A G Torres2, Jared D Evans4, Ernesto T A Marques5.   

Abstract

Saccharomyces boulardii (S. boulardii) is a probiotic yeast related to Saccharomyces cerevisiae (S. cerevisiae) but with distinct genetic, taxonomic and metabolic properties. S. cerevisiae has been used extensively in biotechnological applications. Currently, many strains are available, and multiple genetic tools have been developed, which allow the expression of several exogenous proteins of interest with applications in the fields of medicine, biofuels, the food industry, and scientific research, among others. Although S. boulardii has been widely studied due to its probiotic properties against several gastrointestinal tract disorders, very few studies addressed the use of this yeast as a vector for expression of foreign genes of interest with biotechnological applications. Here we show that, despite the similarity of the two yeasts, not all genetic tools used in S. cerevisiae can be applied in S. boulardii. While transformation of the latter could be obtained using a commercial kit developed for the former, consequent screening of successful transformants had to be optimized. We also show that several genes frequently used in genetic manipulation of S. cerevisiae (e.g., promoters and resistance markers) are present in S. boulardii. Sequencing revealed a high rate of homology (> 96%) between the orthologs of the two yeasts. However, we also observed some of them are not eligible to be targeted for transformation of S. boulardii. This work has important applications toward the potential of this probiotic yeast as an expression system for genes of interest.

Entities:  

Keywords:  Saccharomyces boulardii; expression of foreign sequences; promoter; resistance markers; screening

Mesh:

Substances:

Year:  2013        PMID: 24013355      PMCID: PMC4008461          DOI: 10.4161/bioe.26271

Source DB:  PubMed          Journal:  Bioengineered        ISSN: 2165-5979            Impact factor:   3.269


  37 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Genetic characterization and construction of an auxotrophic strain of Saccharomyces cerevisiae JP1, a Brazilian industrial yeast strain for bioethanol production.

Authors:  Viviane Castelo Branco Reis; André Moraes Nicola; Osmar de Souza Oliveira Neto; Vinícius Daniel Ferreira Batista; Lidia Maria Pepe de Moraes; Fernando Araripe Gonçalves Torres
Journal:  J Ind Microbiol Biotechnol       Date:  2012-08-15       Impact factor: 3.346

3.  Recurrent Clostridium difficile-associated diarrhea and colitis treated with Saccharomyces cerevisiae (Baker's yeast) in combination with antibiotic therapy: a case report.

Authors:  D J Kovacs; T Berk
Journal:  J Am Board Fam Pract       Date:  2000 Mar-Apr

4.  Interaction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infection.

Authors:  Flaviano S Martins; Guillaume Dalmasso; Rosa M E Arantes; Anne Doye; Emmanuel Lemichez; Patricia Lagadec; Veronique Imbert; Jean-François Peyron; Patrick Rampal; Jacques R Nicoli; Dorota Czerucka
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

5.  Inhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in mice.

Authors:  Flaviano S Martins; Angélica T Vieira; Samir D A Elian; Rosa M E Arantes; Fabiana C P Tiago; Lirlândia P Sousa; Helena R C Araújo; Paulo F Pimenta; Cláudio A Bonjardim; Jacques R Nicoli; Mauro M Teixeira
Journal:  Microbes Infect       Date:  2013-01-30       Impact factor: 2.700

6.  Construction of a starch-utilizing yeast by cell surface engineering.

Authors:  T Murai; M Ueda; M Yamamura; H Atomi; Y Shibasaki; N Kamasawa; M Osumi; T Amachi; A Tanaka
Journal:  Appl Environ Microbiol       Date:  1997-04       Impact factor: 4.792

7.  Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics.

Authors:  F C P Tiago; F S Martins; E L S Souza; P F P Pimenta; H R C Araujo; I M Castro; R L Brandão; Jacques R Nicoli
Journal:  J Med Microbiol       Date:  2012-05-11       Impact factor: 2.472

8.  Quantitative phenotyping of inflammatory bowel disease in the IL-10-deficient mouse by use of noninvasive magnetic resonance imaging.

Authors:  Svenja Michael; Lydia M Keubler; Anna Smoczek; Martin Meier; Florian Gunzer; Christoph Pöhlmann; Udo Krause-Buchholz; Hans-J Hedrich; André Bleich
Journal:  Inflamm Bowel Dis       Date:  2013-01       Impact factor: 5.325

9.  New and Redesigned pRS Plasmid Shuttle Vectors for Genetic Manipulation of Saccharomycescerevisiae.

Authors:  Mark K Chee; Steven B Haase
Journal:  G3 (Bethesda)       Date:  2012-05-01       Impact factor: 3.154

10.  Improving health from the inside: Use of engineered intestinal microorganisms as in situ cytokine delivery system.

Authors:  Christoph Pöhlmann; Mandy Thomas; Sarah Förster; Manuela Brandt; Maike Hartmann; André Bleich; Florian Gunzer
Journal:  Bioengineered       Date:  2012-10-30       Impact factor: 3.269

View more
  9 in total

1.  A Mutation in PGM2 Causing Inefficient Galactose Metabolism in the Probiotic Yeast Saccharomyces boulardii.

Authors:  Jing-Jing Liu; Guo-Chang Zhang; In Iok Kong; Eun Ju Yun; Jia-Qi Zheng; Dae-Hyuk Kweon; Yong-Su Jin
Journal:  Appl Environ Microbiol       Date:  2018-05-01       Impact factor: 4.792

2.  Metabolic Engineering of Probiotic Saccharomyces boulardii.

Authors:  Jing-Jing Liu; In Iok Kong; Guo-Chang Zhang; Lahiru N Jayakody; Heejin Kim; Peng-Fei Xia; Suryang Kwak; Bong Hyun Sung; Jung-Hoon Sohn; Hanna E Walukiewicz; Christopher V Rao; Yong-Su Jin
Journal:  Appl Environ Microbiol       Date:  2016-04-04       Impact factor: 4.792

3.  Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory.

Authors:  Yerin Jin; Sora Yu; Jing-Jing Liu; Eun Ju Yun; Jae Won Lee; Yong-Su Jin; Kyoung Heon Kim
Journal:  Microb Cell Fact       Date:  2021-08-18       Impact factor: 5.328

4.  A probiotic yeast-based immunotherapy against Clostridioides difficile infection.

Authors:  Kevin Chen; Yixuan Zhu; Yongrong Zhang; Therwa Hamza; Hua Yu; Ashley Saint Fleur; James Galen; Zhiyong Yang; Hanping Feng
Journal:  Sci Transl Med       Date:  2020-10-28       Impact factor: 17.956

5.  Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii.

Authors:  Lauren E Hudson; Milo B Fasken; Courtney D McDermott; Shonna M McBride; Emily G Kuiper; David B Guiliano; Anita H Corbett; Tracey J Lamb
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

Review 6.  Prospects for immunotherapy and vaccines against Cryptosporidium.

Authors:  Jan R Mead
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

7.  Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii.

Authors:  Indu Khatri; Rajul Tomar; K Ganesan; G S Prasad; Srikrishna Subramanian
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

8.  Heterologous Expression of the Leuconostoc Bacteriocin Leucocin C in Probiotic Yeast Saccharomyces boulardii.

Authors:  Ran Li; Xing Wan; Timo M Takala; Per E J Saris
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02       Impact factor: 4.609

9.  Ferulated Pectins and Ferulated Arabinoxylans Mixed Gel for Saccharomyces boulardii Entrapment in Electrosprayed Microbeads.

Authors:  Federico Ohlmaier-Delgadillo; Elizabeth Carvajal-Millan; Yolanda L López-Franco; María A Islas-Osuna; Valérie Micard; Carole Antoine-Assor; Agustín Rascón-Chu
Journal:  Molecules       Date:  2021-04-23       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.